Economic Evaluation of the Cardiac Insufficiency Bisoprolol Study for the Federal Republic of Germany

@article{Schdlich1998EconomicEO,
  title={Economic Evaluation of the Cardiac Insufficiency Bisoprolol Study for the Federal Republic of Germany},
  author={Dr Peter K. Sch{\"a}dlich and Britta Paschen and Josef Georg Brecht},
  journal={PharmacoEconomics},
  year={1998},
  volume={13},
  pages={147-155}
}
The Cardiac Insufficiency Bisoprolol Study (CIBIS) demonstrates that, for patients with heart failure of different aetiologies, administration of the β1-adrenoceptor blocker bisoprolol as an adjuvant to the standard therapy leads to a significant avoidance of hospital admissions. A pharmacoeconomic analysis of the results of the CIBIS was conducted for the Federal Republic of Germany, and was restricted to direct costs only. The costs of bisoprolol medication and inpatient treatment of heart… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Sozioökonomie der chronischen Herzinsuffizienz

  • R Dinkel, K Büchner, J. Holtz
  • Eine Krankheitskostenstudie in der Bundesrepublik…
  • 1989
Highly Influential
8 Excerpts

and Committees

  • CIBIS Investigator
  • A randomised trial of -blockade in heart failure…
  • 1994
Highly Influential
10 Excerpts

Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy

  • DH Peters, P. Benfield
  • Pharmacoeconomics
  • 1994
Highly Influential
4 Excerpts

Le traitement de l’insuffisance cardiaque: les avantages économiques du bisoprolol

  • E Levy, P. Levy
  • LEGOS, Université Paris-Dauphine, editor. Paris…
  • 1997
1 Excerpt

A randomised trial of  - blockade in heart failure . The Cardiac Insufficiency Bisoprolol Study ( CIBIS )

  • P Lechat
  • Circulation
  • 1994

Similar Papers

Loading similar papers…